The collaborators are developing a multiplexed, lateral-flow diagnostic test to detect 10 bladder cancer biomarkers from a urine sample at the point of care and in the lab.
Corsano Health is announcing that its CardioWatch 287 is a CE medical device certified under EU-MDR standards. THE HAGUE, Netherlands, Nov. 29, 2021 /PRNewswire/ Today, Corsano Health
/PRNewswire/ MedSafety Solutions today announced that it has received the European Union Medical Devices Regulations (EU-MDR) certification as of September.